CMA is delighted to announce the election of two accomplished leaders, Wayne Coote and Blair Norfolk, to CMA’s Board of Directors.
The two new appointments were elected to the CMA Board through a member election process, reflecting the trust and confidence of the association’s membership in their leadership and vision.
Their appointments mark a new chapter of leadership as CMA continues its mission to advance the complementary medicines industry in Australia and beyond.
“We warmly welcome Wayne Coote and Blair Norfolk to the CMA Board. Their extensive industry knowledge, visionary leadership, and shared passion for advancing complementary medicines will be instrumental in driving our goals forward,” said CMA CEO, John O’Doherty.
“Wayne and Blair join a dynamic board dedicated to fostering growth within a framework of best-practice regulation and ensuring the integration of complementary medicines into preventive health policy. With their guidance, we look forward to propelling the industry toward a sustainable and innovative future.”
The two new directors replace departing directors Heidi Roscher and Gladys Peters. CMA extends its heartfelt thanks to Heidi and Gladys for their invaluable contributions during their tenures.
Meet the new directors
Wayne Coote, Founder and Managing Director of Pathway International, has dedicated over 30 years to advancing the complementary medicines industry. Since establishing Pathway International in 1995, Wayne has built a business specialising in scientifically validated, natural ingredients that promote health and wellness. Under his leadership, Pathway has pioneered new healthcare categories, achieving TGA approvals for novel ingredients backed by clinical research, setting benchmarks for quality, safety, and service across diverse sectors, including complementary medicines, food and beverages, pharmaceuticals, and cosmetics.
Wayne brings previous CMA Board experience, having served during the transition from CHC, giving him a unique perspective on the organisation’s evolution. His expertise in international sourcing, supply chain management, and regulatory approvals underscore his commitment to maintaining rigorous product standards. Passionate about innovation and integrity, Wayne looks forward to leveraging his extensive industry knowledge to contribute to CMA’s mission of fostering sustainable growth, quality assurance, and consumer trust.
Blair Norfolk, Founder and Managing Director of Biome Australia, is a seasoned leader in the global nutraceutical and probiotics industry, with over 14 years of experience spanning management and executive roles. Under his leadership, Biome Australia has become a high-growth, values-driven company specialising in evidence-based probiotics, with its flagship brand, Activated Probiotics, recognised for innovative, clinically validated products regulated by TGA, EFSA, and FSANZ.
Blair has been instrumental in facilitating novel clinical trials for disease-targeted probiotics, fostering collaborations between Australian universities and manufacturing partners to advance the body of evidence supporting complementary medicines. A passionate advocate for education and transparency, he has championed initiatives to expand practitioner knowledge and improve patient outcomes.
With a strong focus on innovation, regulatory balance, and sustainability, Blair aims to leverage his global expertise and extensive network to support CMA’s mission of strengthening the industry and advancing the integration of complementary medicines into preventive health strategies.
The CMA Board looks forward to welcoming Wayne and Blair to the next board meeting in February 2025.
Learn more about all of the CMA Board members here.
